These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 36043416

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Elafin Reverses Pulmonary Hypertension via Caveolin-1-Dependent Bone Morphogenetic Protein Signaling.
    Nickel NP, Spiekerkoetter E, Gu M, Li CG, Li H, Kaschwich M, Diebold I, Hennigs JK, Kim KY, Miyagawa K, Wang L, Cao A, Sa S, Jiang X, Stockstill RW, Nicolls MR, Zamanian RT, Bland RD, Rabinovitch M.
    Am J Respir Crit Care Med; 2015 Jun 01; 191(11):1273-86. PubMed ID: 25853696
    [Abstract] [Full Text] [Related]

  • 45. HMGB1/TLR4 promotes hypoxic pulmonary hypertension via suppressing BMPR2 signaling.
    Wang J, Tian XT, Peng Z, Li WQ, Cao YY, Li Y, Li XH.
    Vascul Pharmacol; 2019 Jun 01; 117():35-44. PubMed ID: 30610955
    [Abstract] [Full Text] [Related]

  • 46. BMPR2 gene therapy for PAH acts via Smad and non-Smad signalling.
    Harper RL, Reynolds AM, Bonder CS, Reynolds PN.
    Respirology; 2016 May 01; 21(4):727-33. PubMed ID: 26809239
    [Abstract] [Full Text] [Related]

  • 47. Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2.
    Novoyatleva T, Rai N, Kojonazarov B, Veeroju S, Ben-Batalla I, Caruso P, Shihan M, Presser N, Götz E, Lepper C, Herpel S, Manaud G, Perros F, Gall H, Ghofrani HA, Weissmann N, Grimminger F, Wharton J, Wilkins M, Upton PD, Loges S, Morrell NW, Seeger W, Schermuly RT.
    Commun Biol; 2021 Aug 24; 4(1):1002. PubMed ID: 34429509
    [Abstract] [Full Text] [Related]

  • 48. Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice.
    Long L, MacLean MR, Jeffery TK, Morecroft I, Yang X, Rudarakanchana N, Southwood M, James V, Trembath RC, Morrell NW.
    Circ Res; 2006 Mar 31; 98(6):818-27. PubMed ID: 16497988
    [Abstract] [Full Text] [Related]

  • 49. STING Contributes to Pulmonary Hypertension by Targeting IFN and BMPR2 Signaling through Regulating of F2RL3.
    Deng L, Cao C, Cai Z, Wang Z, Leng B, Chen Z, Kong F, Zhou Z, He J, Nie X, Bian JS.
    Am J Respir Cell Mol Biol; 2024 Sep 31; 71(3):356-371. PubMed ID: 38864771
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. The Role of Bone Morphogenetic Protein Receptor Type 2 (BMPR2) and the Prospects of Utilizing Induced Pluripotent Stem Cells (iPSCs) in Pulmonary Arterial Hypertension Disease Modeling.
    Devendran A, Kar S, Bailey R, Trivieri MG.
    Cells; 2022 Nov 29; 11(23):. PubMed ID: 36497082
    [Abstract] [Full Text] [Related]

  • 52. Interaction of interleukin-6 and the BMP pathway in pulmonary smooth muscle.
    Hagen M, Fagan K, Steudel W, Carr M, Lane K, Rodman DM, West J.
    Am J Physiol Lung Cell Mol Physiol; 2007 Jun 29; 292(6):L1473-9. PubMed ID: 17322283
    [Abstract] [Full Text] [Related]

  • 53. Schistosomiasis-associated pulmonary hypertension unveils disrupted murine gut-lung microbiome and reduced endoprotective Caveolin-1/BMPR2 expression.
    Marinho Y, Villarreal ES, Aboagye SY, Williams DL, Sun J, Silva CLM, Lutz SE, Oliveira SD.
    Front Immunol; 2023 Jun 29; 14():1254762. PubMed ID: 37908354
    [Abstract] [Full Text] [Related]

  • 54. BMPR2 acts as a gatekeeper to protect endothelial cells from increased TGFβ responses and altered cell mechanics.
    Hiepen C, Jatzlau J, Hildebrandt S, Kampfrath B, Goktas M, Murgai A, Cuellar Camacho JL, Haag R, Ruppert C, Sengle G, Cavalcanti-Adam EA, Blank KG, Knaus P.
    PLoS Biol; 2019 Dec 29; 17(12):e3000557. PubMed ID: 31826007
    [Abstract] [Full Text] [Related]

  • 55. Novel Advances in Modifying BMPR2 Signaling in PAH.
    Dannewitz Prosseda S, Ali MK, Spiekerkoetter E.
    Genes (Basel); 2020 Dec 23; 12(1):. PubMed ID: 33374819
    [Abstract] [Full Text] [Related]

  • 56. Bone morphogenetic protein receptor type II deficiency and increased inflammatory cytokine production. A gateway to pulmonary arterial hypertension.
    Soon E, Crosby A, Southwood M, Yang P, Tajsic T, Toshner M, Appleby S, Shanahan CM, Bloch KD, Pepke-Zaba J, Upton P, Morrell NW.
    Am J Respir Crit Care Med; 2015 Oct 01; 192(7):859-72. PubMed ID: 26073741
    [Abstract] [Full Text] [Related]

  • 57. Chronic allergic inflammation causes vascular remodeling and pulmonary hypertension in BMPR2 hypomorph and wild-type mice.
    Mushaben EM, Hershey GK, Pauciulo MW, Nichols WC, Le Cras TD.
    PLoS One; 2012 Oct 01; 7(3):e32468. PubMed ID: 22427841
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.